---
document_datetime: 2025-11-23 10:51:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zeftera.html
document_name: zeftera.html
version: success
processing_time: 0.0632842
conversion_datetime: 2025-12-24 15:08:17.412471
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zeftera (previously Zevtera)

[RSS](/en/individual-human-medicine.xml/66181)

##### Refused

This medicine has been refused authorisation

ceftobiprole

Medicine

Human

Refused

Page contents

## Page contents

- [Overview](#overview)
- [Product details](#product-details)
- [Application details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Zeftera](#more-information-on-zeftera-639)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 18 February 2010, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Zeftera, intended for treatment of complicated skin and soft-tissue infections in adults. The company that applied for authorisation is Janssen-Cilag International N.V. The applicant requested a re-examination of the opinion. After considering the grounds for this request, the CHMP re-examined the opinion, and confirmed the refusal of the marketing authorisation on 24 June 2010.

Questions and answers on the recommendation for the refusal of the marketing authorisation for Zeftera

Adopted

Reference Number: EMA/404483/2010

English (EN) (52.37 KB - PDF)

**First published:** 25/06/2010

**Last updated:** 22/09/2010

[View](/en/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_en.pdf-0)

[Other languages (21)](#file-language-dropdown-37)

български (BG) (90.33 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/bg/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_bg.pdf)

español (ES) (113.4 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/es/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_es.pdf)

čeština (CS) (141.19 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/cs/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_cs.pdf)

dansk (DA) (54.08 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/da/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_da.pdf)

Deutsch (DE) (114.64 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/de/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_de.pdf)

eesti keel (ET) (51.39 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/et/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_et.pdf)

ελληνικά (EL) (152.07 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/el/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_el.pdf)

français (FR) (53.36 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/fr/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_fr.pdf)

italiano (IT) (55.06 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/it/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_it.pdf)

latviešu valoda (LV) (79.57 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/lv/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_lv.pdf)

lietuvių kalba (LT) (78.2 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/lt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_lt.pdf)

magyar (HU) (75.2 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/hu/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_hu.pdf)

Malti (MT) (79.93 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/mt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_mt.pdf)

Nederlands (NL) (52.41 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/nl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_nl.pdf)

polski (PL) (79.39 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/pl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_pl.pdf)

português (PT) (53.82 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/pt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_pt.pdf)

română (RO) (78 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/ro/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_ro.pdf)

slovenčina (SK) (139.33 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/sk/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_sk.pdf)

slovenščina (SL) (134.95 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/sl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_sl.pdf)

Suomi (FI) (54.92 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/fi/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_fi.pdf)

svenska (SV) (112.18 KB - PDF)

**First published:**

25/06/2010

**Last updated:**

22/09/2010

[View](/sv/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorisation-zeftera_sv.pdf)

## Product details

Name of medicine Zeftera (previously Zevtera) Active substance ceftobiprole medocaril International non-proprietary name (INN) or common name ceftobiprole Therapeutic area (MeSH)

- Skin Diseases, Infectious
- Soft Tissue Infections

Anatomical therapeutic chemical (ATC) code J01DI01

## Application details

EMA product number EMEA/H/C/000883 Marketing authorisation applicant Janssen-Cilag International NV Opinion adopted 24/06/2010 Refusal of marketing authorisation 16/09/2010

## Assessment history

Zeftera : EPAR - Public assessment report

English (EN) (993.25 KB - PDF)

**First published:** 21/09/2010

**Last updated:** 22/09/2010

[View](/en/documents/assessment-report/zeftera-epar-public-assessment-report_en.pdf)

#### More information on Zeftera

The Committee for Medicinal Products for Human Use (CHMP) initially granted a positive opinion for this medicine on 20 November 2008. Following this, the applicant provided further data to the CHMP, which issued a revised, negative opinion on 18 February 2010.

CHMP summary of positive opinion for Zevtera

Adopted

Reference Number: EMEA/CHMP/552347/2008

English (EN) (76.55 KB - PDF)

**First published:** 20/11/2008

**Last updated:** 20/11/2008

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-zevtera_en.pdf)

**This page was last updated on** 22/09/2010

## Share this page

[Back to top](#main-content)